Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant

Journal of Infectious Diseases

Volumn 185, Issue 9, 2002, Pages 1229-1237

  Da Costa, Maria M ^a,b   Hogeboom, Charissa J ^a   Holly, Elizabeth A ^a   Palefsky, Joel M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER RISK; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS TYPING;

AMINO ACID SEQUENCE; ANUS NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; RISK;

EID: 0036569121     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340125     Document Type: Article

References (45)

1. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
2. Molecular virology and epidemiology of human papillomavirus and cervical cancer
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
5. Human papillomavirus infection and anal carcinoma: Retrospective analysis by in situ hybridization and the polymerase chain reaction
6. Sexually transmitted infection as a cause of anal cancer
7. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease
8. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men
9. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors
10. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men
11. Papillomavirus and HPV typing
12. Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil
13. Heterogeneity of the human papillomavirus group
14. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA
15. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
16. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain
17. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection
18. Human papillomavirus infection and invasive cervical neoplasia: A study of prevalence and morphology
19. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
20. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
21. Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-1 cervical carcinoma cells
22. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB interactions
23. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
24. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
25. Association of human papillomavirus types 16 and 18 E6 proteins with p53
26. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
27. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
28. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage
29. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation
30. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments
31. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities
32. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
33. Histologic and immunologic associations of an HPV 16 variant in LoSIL smears
34. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype
35. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants
36. Human papillomavirus type 16 variants and risk of cervical cancer
37. The Women's Interagency HIV study
38. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
39. Prevalence and risk factors for anal squamous intraepithelial lesions in women
40. Colposcopic appearance of anal squamous intraepithelial lesions: Relationship to histopathology
41. Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization
42. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective
43. Tree-based models
44. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation
45. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest